logo-loader
viewReNeuron Group PLC

Full interview: ReNeuron in active on-going talks for further potential out-licence deals

ReNeuron Group PLC's (LON:RENE) Michael Hunt caught up with Proactive London's Andrew Scott soon after the release of its interim results to September 2019.

The biotech firm says it's in ongoing discussions with “commercial third parties” interested in out-licence deals across all its programmes.

Quick facts: ReNeuron Group PLC

Price: 151.5 GBX

LSE:RENE
Market: LSE
Market Cap: £48.23 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of ReNeuron Group PLC named herein, including the promotion by the Company of ReNeuron Group PLC in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Klondike Gold work along the Lonestar fault sees high grade...

Klondike Gold (CVE: KG) CEO Peter Tallman sat down with Steve Darling from Proactive Vancouver to discuss his company selling their BC assets to Ximen mining. Peter talked about why they did it and what they received in return.  Tallman also told Proactive about the results from their...

14 hours, 40 minutes ago

2 min read